awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42641870-03C73F00-FDA7-4BB1-BC45-6686910A4170
Q42641870-03C73F00-FDA7-4BB1-BC45-6686910A4170
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42641870-03C73F00-FDA7-4BB1-BC45-6686910A4170
Antitumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer.
P2860
Q42641870-03C73F00-FDA7-4BB1-BC45-6686910A4170
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42641870-03C73F00-FDA7-4BB1-BC45-6686910A4170
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0f40b5eb4eacbeaf2a6d5a00879fa55cf03d0818
P2860
Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy.